ONYX PHARMACEUTICALS INC's ticker is and the CUSIP is 683399909. A total of 11 filers reported holding ONYX PHARMACEUTICALS INC in Q3 2013. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2013 | $42,000 | – | 8,356 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Hudson Bay Capital Management LP | 523,700 | $65,305,000 | 2.41% |
| GROUP ONE TRADING, L.P. | 772,900 | $96,357,000 | 1.84% |
| ALPINE ASSOCIATES ADVISORS | 115,000 | $14,337,000 | 0.58% |
| CR Intrinsic Investors, LLC | 100,000 | $12,467,000 | 0.39% |
| Pentwater Capital Management LP | 81,900 | $10,213,000 | 0.28% |
| PointState Capital LP | 100,000 | $12,470,000 | 0.21% |
| SABBY MANAGEMENT, LLC | 199 | $2,481,000 | 0.16% |
| Citadel Advisors | 519,800 | $64,804,000 | 0.10% |
| Timber Hill LLC | 37,800 | $4,714,000 | 0.02% |
| HALCYON OFFSHORE ASSET MANAGEMENT LLC | 8,356 | $42,000 | 0.01% |